Momenta Pharmaceuticals, Inc.

Momenta is a biotechnology company that discovers, develops and commercializes novel therapeutics for the treatment of immune-mediated diseases.

Business Model:

Revenue: $30M

Employees: 51-200

Rankings

Detailed Momenta Pharmaceuticals, Inc. Information

Momenta Pharmaceuticals, Inc. was acquired by Johnson &a; Johnson.
The acquisition happend on 2020-08-19.
Details of the transaction were not public

Geographic Data

Momenta Pharmaceuticals, Inc. headquarters map

Address: 301 Binney Street

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

series c

Raised Last:

$21M

Raised Total:

$40M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Momenta is a biotechnology company that discovers, develops and commercializes novel therapeutics for the treatment of immune-mediated diseases.

Contact Phone:
+16174919700

Contact Email:

Momenta Pharmaceuticals, Inc. went public on 7/2/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/2/2004

Ticker Symbol:
MNTA

IPO Price:
$6.5/share

Amount Raised:
$35M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research